Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 28, 2022
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
Robin Garner Initiated (XERS) at Strong Buy and Held Target at $6.5 on, Apr 28th, 2022
Robin Garner of Craig-Hallum, Initiated "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy and Held Target at $6.5 on, Apr 28th, 2022.
Robin has made no other calls on XERS in the last 4 months.
There are 3 other peers that have a rating on XERS. Out of the 3 peers that are also analyzing XERS, 0 agree with Robin's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Robin
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $6 on, Wednesday, March 16th, 2022
- Roanna Ruiz of "SVB Leerink" Maintained at Buy with Decreased Target to $6 on, Wednesday, February 16th, 2022
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $5.4 on, Friday, December 31st, 2021
